Taken together with our previous results demonstrating that phosphorylation of Akt is reduced by PCP4/PEP19 knockdown [16], our current findings implicate PCP4/PEP19 as a novel factor in the upregulation of EMT in human breast cancer. This evidence concerns the gene AKT1 and breast cancer.